Kaletra - 0074-0522-60 - (Lopinavir and Ritonavir)

Alphabetical Index


Drug Information of Kaletra

Product NDC: 0074-0522
Proprietary Name: Kaletra
Non Proprietary Name: Lopinavir and Ritonavir
Active Ingredient(s): 100; 25    mg/1; mg/1 & nbsp;   Lopinavir and Ritonavir
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Kaletra

Product NDC: 0074-0522
Labeler Name: AbbVie Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021906
Marketing Category: NDA
Start Marketing Date: 20100618

Package Information of Kaletra

Package NDC: 0074-0522-60
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE (0074-0522-60)

NDC Information of Kaletra

NDC Code 0074-0522-60
Proprietary Name Kaletra
Package Description 60 TABLET, FILM COATED in 1 BOTTLE (0074-0522-60)
Product NDC 0074-0522
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lopinavir and Ritonavir
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20100618
Marketing Category Name NDA
Labeler Name AbbVie Inc.
Substance Name LOPINAVIR; RITONAVIR
Strength Number 100; 25
Strength Unit mg/1; mg/1
Pharmaceutical Classes HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC]

Complete Information of Kaletra


General Information